Novartis Data at ERS Shows Efficacy of Once-Daily COPD Portfolio Versus …

Published September 3, 2012

Novartis data at ERS shows efficacy of once-daily COPD portfolio versus …
Filed under: dual diagnosis treatment

"We are very excited that the Novartis data at ERS brings us one step further to delivering on the promise to provide COPD patients and physicians with a range of innovative treatments," said David Epstein, Head of Novartis Pharmaceuticals. "These …
{Source}

Blood cancers have paved the way for better therapies for many types of the …
Filed under: dual diagnosis treatment

Collectively, they also account for 9% of all new diagnoses in the U.S., making them the fourth most commonly occurring cancers behind lung, prostate and breast cancer. More than a million adults in the … He combined monoclonal antibodies with …
{Source}

Dual Diagnosis Treatment

dual-diagnosis-treatment.org Discover how to choose the best Dual Diagnosis Treatment. This decision could be the most important one you can make in your life. Click on the link to get the FREE guide now.